StriveWeekly Online Mental Health Trial Post-pandemic
Randomized Controlled Trial (RCT) of StriveWeekly for Anxiety and Depression Prevention for College Students During COVID-19 (Coronavirus Disease 2019)
1 other identifier
interventional
538
1 country
1
Brief Summary
With the COVID-19 pandemic completely altering the landscape of higher education, students have been experiencing more stress than ever. With Harvard University's plan for students to return to campus for the 2021-2022 academic year, offering an online mental health program such as StriveWeekly could provide students with stress management support as they transition back after 1.5 years of remote learning. This study will use a randomized controlled trial design to test the effectiveness of a waitlist versus StriveWeekly. This study will allow us to test if a program that has previously demonstrated effectiveness with university students in reducing anxiety and depression symptoms will still be effective after the unprecedented amount of stressors during a global pandemic. Primary aim: We aim to evaluate the effectiveness of StriveWeekly in preventing or reducing symptoms of anxiety and depression. The use of a waitlist condition will allow us to experimentally assess if the online intervention is responsible for decreasing / preventing worsened anxiety, depression, and stress symptoms over time. Given the previously established effectiveness of StriveWeekly as an indicated prevention program, we expect students in the intervention condition to experience significantly better symptoms compared to the waitlist from baseline to posttest. Alternatively, if the transition back from remote learning and/or the broad pandemic context interferes with the acceptability or effectiveness of StriveWeekly, then we might expect to see little to no significant differences between the online intervention condition and waitlist condition from baseline to posttest. Secondary aims include: (a) testing moderators of intervention effectiveness and (b) evaluating the intervention in terms of acceptability (e.g., feedback on program name; demographically representativeness of student user sample; satisfactory adherence and satisfaction rates). Exploratory moderation analyses across groups will help determine whether or not the intervention condition produces unique or additive effects for students with certain characteristics over and above changes demonstrated by similar students in the waitlist condition. Acceptability analyses will allow for more nuanced evaluation of StriveWeekly's effectiveness as a program, beyond its ability to facilitate symptom reduction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable anxiety
Started May 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 19, 2021
CompletedFirst Submitted
Initial submission to the registry
June 9, 2021
CompletedFirst Posted
Study publicly available on registry
June 16, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 18, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 10, 2022
CompletedResults Posted
Study results publicly available
September 3, 2024
CompletedSeptember 3, 2024
August 1, 2024
11 months
June 9, 2021
June 1, 2023
August 29, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Depression Anxiety and Stress Scale (DASS-21)
Change in self-reported symptoms of depression, anxiety, and stress (completed via online surveys). Items are rated on a scale of 0-3, with higher scores indicating worse symptoms. Subscale total scores range from 0-21, and DASS-21 total scores range from 0-63.
Baseline to Posttest (~8 weeks)
Secondary Outcomes (2)
Perceived Stress Scale
Baseline to Posttest (~8 weeks)
The Warwick-Edinburgh Mental Wellbeing Scales
Baseline to Posttest (~8 weeks)
Study Arms (2)
Immediate Intervention Condition
EXPERIMENTALParticipants in this condition will receive 7-8 weeks of online intervention modules. Specific modules will be selected based on a campus-wide needs assessment conducted in May 2021.
Waitlist Condition
NO INTERVENTIONParticipants in this condition will wait to receive StriveWeekly until after the Immediate Intervention condition is complete and participants from both conditions have completed the posttest survey.
Interventions
The intervention (app.striveweekly.com) delivers content via independent modules. Principles covered in content modules: Psychoeducation; Self-monitoring; Values-based goal-setting; Behavioral activation; Cognitive restructuring; Sleep hygiene; Time management; Interpersonal avoidance exposures; Physical exercise; Mindfulness; Relaxation strategies; Maintenance planning. Modules get released week-by-week, and participants are self-guided through content. To facilitate skills practice, every module is accompanied by: a weekly intro email and reminder emails; an "extras" section for tips/suggestions; and a weekly prize drawing. The "Dashboard" section of the intervention displays user progress, including self-rating graphs and a history log of skills practice. The "Campus" section of this dashboard provided: campus-specific announcements; referrals to relevant campus wellness resources; and an anonymous livestream of all campus users' activity.
Eligibility Criteria
You may qualify if:
- enrolled as a student at Harvard College (academic year 2021-2022)
You may not qualify if:
- invalid data reporting (e.g., straight-lined responses to surveys)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Harvard University
Cambridge, Massachusetts, 02138, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Leslie Rith-Najarian, Principal Investigator
- Organization
- Strive Weekly Inc
Study Officials
- STUDY CHAIR
Katie McLaughlin, PhD
Harvard University
- PRINCIPAL INVESTIGATOR
Leslie Rith-Najarian, PhD
Strive Weekly Inc
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 9, 2021
First Posted
June 16, 2021
Study Start
May 19, 2021
Primary Completion
April 18, 2022
Study Completion
June 10, 2022
Last Updated
September 3, 2024
Results First Posted
September 3, 2024
Record last verified: 2024-08